Roundtable discussion. Cost justification of innovative drugs through assessment of total health care costs.
School of Medicine, Wayne State University, Detroit, MI.
M J
MJ
Rybak
R
R
Allen
P C
PC
Craven
R
R
Freeman
C H
CH
Nightingale
C
C
Normand
E
E
Rubinstein
G S
GS
Schaison
G
G
Whitelaw
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D005060:Europe; D005572:Formularies, Hospital as Topic; D017048:Health Care Costs; D005102:Health Expenditures; D006295:Health Resources / Q000458:organization & administration; D010344:Patient Advocacy; D013222:State Medicine; D014481:United States